JPS60112792A - ６―デスオキシー６―メチレンナロキソンおよび６―デスオキシー６―メチレンナルトレキソンの製法 - Google Patents

６―デスオキシー６―メチレンナロキソンおよび６―デスオキシー６―メチレンナルトレキソンの製法

Info

Publication number
JPS60112792A
JPS60112792A JP59230008A JP23000884A JPS60112792A JP S60112792 A JPS60112792 A JP S60112792A JP 59230008 A JP59230008 A JP 59230008A JP 23000884 A JP23000884 A JP 23000884A JP S60112792 A JPS60112792 A JP S60112792A
Authority
JP
Japan
Prior art keywords
methylene
deoxy
disoxy
naloxone
reaction mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP59230008A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0432831B2 (cg-RX-API-DMAC10.html
Inventor
ピーター・シイ・メルツアー
ジヨタム・ダブリユウ・コイ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Key Pharmaceuticals Inc
Original Assignee
Key Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Key Pharmaceuticals Inc filed Critical Key Pharmaceuticals Inc
Publication of JPS60112792A publication Critical patent/JPS60112792A/ja
Publication of JPH0432831B2 publication Critical patent/JPH0432831B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08—Oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Addiction (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP59230008A 1983-11-01 1984-10-30 ６―デスオキシー６―メチレンナロキソンおよび６―デスオキシー６―メチレンナルトレキソンの製法 Granted JPS60112792A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US547676 1983-11-01
US06/547,676 US4535157A (en) 1983-11-01 1983-11-01 Process for making 6-desoxy-6-methylenenaloxone and 6-desoxy-6-methylenenaltrexone

Publications (2)

Publication Number Publication Date
JPS60112792A true JPS60112792A (ja) 1985-06-19
JPH0432831B2 JPH0432831B2 (cg-RX-API-DMAC10.html) 1992-06-01

Family

ID=24185669

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59230008A Granted JPS60112792A (ja) 1983-11-01 1984-10-30 ６―デスオキシー６―メチレンナロキソンおよび６―デスオキシー６―メチレンナルトレキソンの製法

Country Status (3)

Country Link
US (1) US4535157A (cg-RX-API-DMAC10.html)
EP (1) EP0140367A3 (cg-RX-API-DMAC10.html)
JP (1) JPS60112792A (cg-RX-API-DMAC10.html)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62138429A (ja) * 1985-12-02 1987-06-22 ザ・デュポン・メルク・ファーマシュウティカル・カンパニー 経口投与のための麻薬拮抗剤
JP2012527489A (ja) * 2009-05-25 2012-11-08 ハー・ルンドベック・アクチエゼルスカベット ナルトレキソンからの塩酸ナルメフェンの調製
JP2016199566A (ja) * 2010-11-05 2016-12-01 ハー・ルンドベック・アクチエゼルスカベット ナルトレキソンの製造方法

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3690457T1 (cg-RX-API-DMAC10.html) * 1985-09-06 1987-08-06
US5922705A (en) * 1996-04-12 1999-07-13 Intensive Narcotic Detoxification Centers Of America, Llc Rapid narcotic detoxification
US5919760A (en) * 1996-04-12 1999-07-06 Intensive Narcotic Detoxification Centers Of America, Llc Method for treating acute and severe diarrhea
US5783583A (en) * 1996-04-12 1998-07-21 Simon; David Lew 17-(cyclopropylmethyl)-4,5alpha-epoxy-6-methylenemorphinan-3,14-diol, hydrochloride salt for the purpose of rapid narcotic detoxification
US6271240B1 (en) 1996-05-06 2001-08-07 David Lew Simon Methods for improved regulation of endogenous dopamine in prolonged treatment of opioid addicted individuals
CN1050130C (zh) * 1997-07-04 2000-03-08 卢正堂 纳洛酮酸脂和纳屈酮酸脂及系列物和制备方法
DK2561860T3 (en) * 2002-05-31 2018-04-30 Titan Pharmaceuticals Inc Implantable polymer device for prolonged release of buprenorphine
DE60329520D1 (de) * 2002-11-08 2009-11-12 Mallinckrodt Inc Verfahren zur herstellung von quaternäre n-alkyl morphinan alkaloid salzen
US7323565B2 (en) * 2002-11-11 2008-01-29 Mallinckrodt Inc. Method for the catalytic production of hydrocodone and hydromorphone
US7399858B2 (en) * 2002-11-11 2008-07-15 Mallinckrodt Inc. Method for the catalytic production of hydrocodone, hydromorphone, and derivatives thereof
US7321038B2 (en) * 2002-11-11 2008-01-22 Mallinckrodt Inc. Method for the catalytic production of hydrocodone and hydromorphone
KR101152183B1 (ko) * 2003-03-31 2012-06-15 타이탄 파머슈티컬즈 인코퍼레이티드 도파민 아고니스트의 지속 방출을 위한 이식가능한 폴리머디바이스
CA2580694A1 (en) * 2004-09-23 2006-03-30 Alexander Michalow Methods for regulating neurotransmitter systems by inducing counteradaptations
US20080045610A1 (en) * 2004-09-23 2008-02-21 Alexander Michalow Methods for regulating neurotransmitter systems by inducing counteradaptations
ATE517869T1 (de) * 2006-09-20 2011-08-15 Mallinckrodt Inc Herstellung substituierter morphinan-6-one und salzen und zwischenprodukten davon
US9040726B2 (en) 2007-03-06 2015-05-26 Mallinckrodt Llc Process for the preparation of quaternary N-alkyl morphinan alkaloid salts
CA2707757C (en) * 2007-03-06 2017-01-03 Peter X. Wang Process for the preparation of quaternary n-alkyl morphinan alkaloid salts
ES2549904T3 (es) * 2008-05-27 2015-11-03 Mallinckrodt Llc Procesos y compuestos para la preparación de normorfinanos
EP2331508B1 (en) 2008-09-03 2014-11-12 Mallinckrodt LLC Substituted berbines and processes for their synthesis
UA102128C2 (en) 2008-12-05 2013-06-10 Х. Луннбек А/С Nalmefene hydrochloride dihydrate
WO2011154827A2 (en) 2010-06-11 2011-12-15 Rhodes Technologies Transition metal-catalyzed processes for the preparation of n-allyl compounds and use thereof
CN103012416B (zh) * 2011-09-28 2015-07-01 辽宁海思科制药有限公司 一种盐酸纳美芬的制备方法
TWI560170B (en) 2011-12-06 2016-12-01 Lundbeck & Co As H Process for recovery of nalmefene hydrochloride
CN102584840A (zh) * 2011-12-28 2012-07-18 南京优科生物医药有限公司 一种制备纳美芬化合物的方法
US20140155608A1 (en) 2012-05-03 2014-06-05 H. Lundbeck A/S Method for the manufacturing of naltrexone
US20140005216A1 (en) 2012-06-27 2014-01-02 H. Lundbeck A/S Nalmefene for reduction of alcohol consumption in specific target populations
CN103204859B (zh) * 2013-04-25 2015-12-02 四川海思科制药有限公司 一种盐酸纳美芬化合物及其制备方法
US20170042887A1 (en) 2014-04-22 2017-02-16 Otsuka Pharmaceutical. Co., Ltd. Combination of Brexpiprazole and Nalmefene and Use Thereof for Treating Substance-Related Disorders
CN104513251A (zh) * 2014-11-28 2015-04-15 安徽悦康凯悦制药有限公司 一种盐酸纳美芬的制备方法
RU2712232C1 (ru) * 2018-10-05 2020-01-27 Федеральное государственное унитарное предприятие "Научно-исследовательский институт гигиены, профпатологии и экологии человека" Федерального медико-биологического агентства Улучшенный способ получения налмефена из налтрексона
US10927121B1 (en) 2019-12-20 2021-02-23 Southwest Research Institute Technologies for removing residual solvent from nalmefene hydrochloride and producing crystalline nalmefene hydrochloride monohydrate, monosolvate, or crystalline nalmefene hydrochloride dihydrate
US20240109907A1 (en) 2021-01-28 2024-04-04 Rhodes Technologies Process for crystallizing nalmefene hydrochloride
CN117986261B (zh) * 2024-04-02 2024-06-18 成都瑞尔医药科技有限公司 一种盐酸纳美芬母液的回收套用方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3814768A (en) * 1971-11-26 1974-06-04 Lewenstein E 6-methylene-6-desoxy dihydro morphine and codeine derivatives and pharmaceutically acceptable salts
US4322426A (en) * 1980-04-28 1982-03-30 E. I. Du Pont De Nemours And Company 17-Substituted-6-desoxy-7,8-dihydro-6α-methylnoroxymorphone narcotic antagonists

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62138429A (ja) * 1985-12-02 1987-06-22 ザ・デュポン・メルク・ファーマシュウティカル・カンパニー 経口投与のための麻薬拮抗剤
JP2012527489A (ja) * 2009-05-25 2012-11-08 ハー・ルンドベック・アクチエゼルスカベット ナルトレキソンからの塩酸ナルメフェンの調製
JP2016199566A (ja) * 2010-11-05 2016-12-01 ハー・ルンドベック・アクチエゼルスカベット ナルトレキソンの製造方法

Also Published As

Publication number Publication date
EP0140367A3 (en) 1988-07-20
EP0140367A2 (en) 1985-05-08
US4535157A (en) 1985-08-13
JPH0432831B2 (cg-RX-API-DMAC10.html) 1992-06-01

Similar Documents

Publication Publication Date Title
JPS60112792A (ja) ６―デスオキシー６―メチレンナロキソンおよび６―デスオキシー６―メチレンナルトレキソンの製法
DE69002248T2 (de) 1,2-Cyclohexylaminoarylamide zu Verwendung als Analgetika.
DE2265255C2 (de) 2-Aminoäthylhexahydrophenanthren-Derivate und deren Säureadditionssalze
JPS6051174A (ja) 新規アリ−ルピペリジン誘導体の製造方法
DE3306302A1 (de) Piperazinarylderivate, verfahren zu deren herstellung und deren therapeutische anwendung
FR2582309A1 (fr) Nouveaux derives du morphinane et de la morphine, leur preparation, leur application comme medicaments et les compositions pharmaceutiques les contenant
US4001248A (en) N-cycloalkylmethyl decahydroisoquinolines
JPH09508893A (ja) シグマ受容体のリガンドである 新規２−アリールアルケニルアザシクロアルカン誘導体、その製造方法及び治療薬としてのその使用
AU8327291A (en) Propylamine derivatives
EP0106486A2 (en) Improvements in or relating to novel octahydrobenz(f)isoquinolines
US3308159A (en) 1-phenyl-1-cycloalkyl-omega-amino-1-alkylene compounds
DE2254566A1 (de) Substituierte aryl- und aralkylamide
US3222399A (en) Cyclopentylbenzylamines
US3503952A (en) Azoxybis(2-phenylacrylic acid,3-tropanyl esters)
Krapcho et al. General synthetic route to malonamic acids and 3-thiomalonamic acids. Amidations and thioamidations of. alpha. anions of carboxylate salts with alkyl and aryl isocyanates and isothiocyanates
King et al. 40. Synthetic mydriatics. Diphenylchloroacetyl chloride as a reagent for the preparation of benzilic esters of tertiary amino-alcohols
EP0011282B1 (de) Thienylbenzoesäurederivate, Verfahren zu ihrer Herstellung und pharmazeutische Präparate auf Basis dieser Verbindungen
EP0077536A2 (en) 2'-Substituted-spiro(benzofuran-2(3H),1'-cycloalkanes), a process for preparing same, pharmaceutical compositions containing such compounds and their use as medicaments
DE2207430A1 (de) Verfahren zur herstellung von 1,2,4,5tetrahydro-3h-3-benzazepinen und daraus erhaltener produkte
US3555093A (en) 2,alpha-dimenthyl-beta-ethyl-beta-(p-fluorophenyl)-ethylamines and the salts thereof
Costa et al. Pentaatomie heteroaromatic cations. Note III. A Convenient Synthesis of Aldehydes from Carboxylic Acids via 2‐Substituted 1, 3‐Benzoxathiolium Perchlorates
CA1328106C (en) Anticholinergic compounds, pharmaceutical compositions and method of treatment
US3580943A (en) Dibenzocycloheptene derivatives
US3035059A (en) Saturated quinoline and indole derivatives
US3649628A (en) Process for producing substituted cyclohexene compounds

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term